pentetic acid has been researched along with paclitaxel in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Averette, HE; Method, MW; Penalver, MA; Rodriguez, M; Serafini, AN; Sevin, BU | 1 |
Hunter, NR; Inoue, T; Kim, EE; Li, C; Liu, CW; Milas, L; Tansey, W; Wallace, S; Yang, DJ; Yu, DF | 1 |
Higuchi, T; Hunter, N; Inoue, T; Kim, EE; Li, C; Milas, L; Oriuchi, N; Podoloff, DA; Wallace, S; Yang, DJ; Yu, D | 1 |
Barbet, J; Campion, L; Chatal, JF; Chérel, M; Faivre-Chauvet, A; Kraeber-Bodéré, F; Mirallié, E; Saï-Maurel, C; Supiot, S; Thédrez, P | 1 |
Busby, E; Carey, D; Forero, A; Grizzle, WE; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Robert, F; Shen, S | 1 |
de Korte, MA; de Vries, EG; Gietema, JA; Jager, PL; Jonkman, S; Kosterink, JG; Lub-De Hooge, MN; Perik, PJ; Sleijfer, DT; van der Graaf, WT; van Veldhuisen, DJ | 1 |
Brechbiel, MW; Kelly, MP; Lee, FT; Scott, AM; Smyth, FE; Tahtis, K | 1 |
Chen, X; Li, M; Lin, J; Liu, H; Lv, S; Song, W; Tang, Z; Zhang, D | 1 |
Feng, L; Li, J; Liu, F; Liu, Y; Yu, D; Zhang, N | 1 |
Gao, L; Li, Q; Liu, X; Lu, W; Peng, T; Sun, J; Sun, L; Wang, J; Wang, Y; Yan, Z; Yu, J; Yu, L; Zhou, J; Zhu, J | 1 |
1 review(s) available for pentetic acid and paclitaxel
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for pentetic acid and paclitaxel
Article | Year |
---|---|
The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Laparotomy; Mice; Middle Aged; Neoplasm, Residual; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Radioimmunodetection; Remission Induction; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chelating Agents; Clinical Trials as Topic; Disease Progression; Edetic Acid; Female; Glycoproteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radiometry; Thrombocytopenia; Treatment Outcome; Up-Regulation; Yttrium Radioisotopes | 2005 |
9 other study(ies) available for pentetic acid and paclitaxel
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autoradiography; Chelating Agents; Female; Indium Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Paclitaxel; Pentetic Acid; Radionuclide Imaging; Tissue Distribution | 1997 |
Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel.
Topics: Animals; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Liver; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Ovarian Neoplasms; Paclitaxel; Pentetic Acid; Radionuclide Imaging; Rats | 1999 |
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
Topics: Animals; Antibodies, Bispecific; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality Therapy; Doxorubicin; Humans; Immunoglobulin G; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Pentetic Acid; Radiation-Sensitizing Agents; Radioimmunotherapy; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Disease Progression; Female; Heart Diseases; Heart Neoplasms; Humans; Indium Radioisotopes; Middle Aged; Natriuretic Peptide, Brain; Neoplasm Metastasis; Paclitaxel; Pentetic Acid; Peptide Fragments; Predictive Value of Tests; Receptor, ErbB-2; Tomography, Emission-Computed, Single-Photon; Trastuzumab; Troponin I | 2006 |
Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Bismuth; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Immunoglobulin Fab Fragments; Isothiocyanates; Lewis Blood Group Antigens; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Survival Rate; Tissue Distribution; Xenograft Model Antitumor Assays | 2007 |
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hydrogen-Ion Concentration; Lysine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Oxidation-Reduction; Paclitaxel; Pentetic Acid; Polyethylene Glycols; Polymers | 2014 |
Theranostic Polymeric Micelles for the Diagnosis and Treatment of Hepatocellular Carcinoma.
Topics: alpha-Fetoproteins; Animals; Antibodies; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Avidin; Biotin; Biotinylation; Carcinoma, Hepatocellular; Gold; Hep G2 Cells; Humans; Lactates; Liver Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Metal Nanoparticles; Mice; Micelles; Neoplasm Transplantation; Paclitaxel; Pentetic Acid; Phototherapy; Polyesters; Polyethylene Glycols; Polymers; Singlet Oxygen | 2015 |
A Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Gadolinium; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Pentetic Acid; Polyglutamic Acid; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2017 |